# An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients

> **NCT03392337** · NA · RECRUITING · sponsor: **Psoriasis Treatment Center of Central New Jersey** · enrollment: 30 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DEVICE:** Narrowband UVB phototherapy

## Key facts

- **NCT ID:** NCT03392337
- **Lead sponsor:** Psoriasis Treatment Center of Central New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-11-07
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03392337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03392337, "An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03392337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*